Literature DB >> 7240961

Cholesterol metabolism in hypothyroidism and hyperthyroidism in man.

J J Abrams, S M Grundy.   

Abstract

Studies were carried out on cholesterol metabolism in 11 nonobese patients and 16 obese patients with hypothyroidism and 13 with hyperthyroidism. The patients underwent several investigations under metabolic ward conditions. Hypothyroid patients usually had an increase in low density lipoprotein (LDL)-cholesterol. Several mechanisms may have combined to cause a high LDL. For instance, the obese hypothyroid patients had an increase in cholesterol synthesis. Absorption of cholesterol also was increased frequently. However, other mechanisms not explored in this study probably contributed to most of the fall in LDL-cholesterol. Treatment of hypothyroid patients produced the expected fall in LDL. One possible mechanism could be that thyroid hormones enhance the conversion of cholesterol into bile acids; this mechanism has been suggested by other workers from animal studies. However, no evidence was obtained in either hypothyroid or hyperthyroid patients that thyroid hormones alter synthesis of bile acids. On the other hand, the hormones appeared to increase the synthesis of cholesterol. Patients with hypothyroidism frequently had supersaturated bile. The cause was mostly an enhanced secretion of biliary cholesterol associated with a tendency to obesity and increased synthesis of cholesterol. In contrast, the usually thin hyperthyroid patients did not have supersaturated bile. The studies show that thyroid hormones a) influence LDL-cholesterol by an action on the catabolism of LDL-independent of alterations in synthesis, catabolism, absorption, or excretion: b) stimulate synthesis of cholesterol; and c) affect biliary lipid metabolism in large part by influencing energy balance and cholesterol synthesis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7240961

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  25 in total

1.  Statin resistant dyslipidemia in a patient treated with amiodarone.

Authors:  Ahmad Al-Sarraf; Min Li; Jiri Frohlich
Journal:  BMJ Case Rep       Date:  2011-10-11

Review 2.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

3.  Homeostatic Model Assessment-Insulin Resistance (HOMA-IR 2) in Mild Subclinical Hypothyroid Subjects.

Authors:  Shreejita Sengupta; T Jaseem; Jayachidambaram Ambalavanan; Anupama Hegde
Journal:  Indian J Clin Biochem       Date:  2017-03-18

4.  Cholesterol esterase activity of human intestinal mucosa.

Authors:  M Ponz de Leon; F Carubbi; P Di Donato; N Carulli
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

5.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

6.  Thyroid hormone action on intermediary metabolism. Part II: Lipid metabolism in hypo- and hyperthyroidism.

Authors:  M J Müller; H J Seitz
Journal:  Klin Wochenschr       Date:  1984-01-16

7.  Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.

Authors:  B R Ito; B-H Zhang; E E Cable; X Song; J M Fujitaki; D A MacKenna; C E Wilker; B Chi; P D van Poelje; D L Linemeyer; M D Erion
Journal:  Br J Pharmacol       Date:  2009-01-22       Impact factor: 8.739

8.  Serum paraoxonase 1 activity is decreased in thyroid dysfunction.

Authors:  F Azizi; F Raiszadeh; M Solati; A Etemadi; M Rahmani; M Arabi
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

9.  A case of hypothyroidism and type 2 diabetes associated with type V hyperlipoproteinemia and eruptive xanthomas.

Authors:  Jeong Rang Park; Tae Sik Jung; Jung Hwa Jung; Gyeong-Won Lee; Me Ae Kim; Ki-Jong Park; Deok Ryong Kim; Se-Ho Chang; Soon Il Chung; Jong Ryeal Hahm
Journal:  J Korean Med Sci       Date:  2005-06       Impact factor: 2.153

10.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.